Apogee Therapeutics, Inc. (APGE)

135.07 -0.01 (-0.01%) USD  |  NASDAQ  |  Sep 02, 16:00
135.10 +0.03 (+0.02%) Pre-Market: 20:00
More

Apogee Therapeutics Cost of Goods Sold (% of Quarterly Revenues)

Cost of Goods Sold (% of Quarterly Revenues) Chart

View Cost of Goods Sold (% of Quarterly Revenues) for APGE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cost of Goods Sold (% of Quarterly Revenues) Chart
Start Trial

Historical Cost of Goods Sold (% of Quarterly Revenues) Data

View and export this data back to . Start Trial.
Date Value

Cost of Goods Sold Definition

Returns the Cost of Goods Sold (COGS) for the period and date(s) requested in local currency by default.

Read full definition.

Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cost of Goods Sold (% of Quarterly Revenues) Benchmarks

View Cost of Goods Sold (% of Quarterly Revenues) Benchmarks
Start Trial
Cogent Biosciences, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade
Intellia Therapeutics, Inc. Upgrade
Revolution Medicines, Inc. --
Erasca, Inc. --